Parmar Kalindi, D'Andrea Alan, Niedernhofer Laura J
Department of Radiation Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA.
Mutat Res. 2009 Jul 31;668(1-2):133-40. doi: 10.1016/j.mrfmmm.2009.03.015. Epub 2009 Apr 10.
Fanconi anemia is a rare inherited disease characterized by congenital anomalies, growth retardation, aplastic anemia and an increased risk of acute myeloid leukemia and squamous cell carcinomas. The disease is caused by mutation in genes encoding proteins required for the Fanconi anemia pathway, a response mechanism to replicative stress, including that caused by genotoxins that cause DNA interstrand crosslinks. Defects in the Fanconi anemia pathway lead to genomic instability and apoptosis of proliferating cells. To date, 13 complementation groups of Fanconi anemia were identified. Five of these genes have been deleted or mutated in the mouse, as well as a sixth key regulatory gene, to create mouse models of Fanconi anemia. This review summarizes the phenotype of each of the Fanconi anemia mouse models and highlights how genetic and interventional studies using the strains have yielded novel insight into therapeutic strategies for Fanconi anemia and into how the Fanconi anemia pathway protects against genomic instability.
范可尼贫血是一种罕见的遗传性疾病,其特征为先天性异常、生长发育迟缓、再生障碍性贫血以及急性髓系白血病和鳞状细胞癌风险增加。该疾病由范可尼贫血通路所需蛋白质编码基因的突变引起,范可尼贫血通路是一种对复制应激(包括由导致DNA链间交联的基因毒素引起的应激)的反应机制。范可尼贫血通路的缺陷会导致基因组不稳定和增殖细胞凋亡。迄今为止,已鉴定出13个范可尼贫血互补组。其中五个基因以及第六个关键调控基因在小鼠中被敲除或突变,以创建范可尼贫血小鼠模型。本综述总结了每个范可尼贫血小鼠模型的表型,并强调了使用这些品系进行的遗传和干预研究如何为范可尼贫血的治疗策略以及范可尼贫血通路如何预防基因组不稳定带来了新的见解。